Another research report recently uploaded onto the company website. RBS Morgans wrote: ?Net debt and corporate costs give a valuation of A$2.34/CAH share (from A$2.06). Our target remains at A$2.00, a 15% discount to valuation.? Refer to link below for full details:http://www.catalparesources.com.au/_content/documents/960.pdfBut of course these valuations mean nothing unless we see a price rise in line with expectation!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025